Alexion Pharmaceuticals Agrees to $21.5 Million Settlement With SEC in Bribery Case

Alexion Pharmaceuticals (NASDAQ:ALXN) is reaching into its coffers to settle charges leveled against it by the Securities and Exchange Commission. The company will hand over a total of roughly $21.5 million in disgorgement, civil penalties, and pre-judgment interest to the regulator.